CFTR modulator therapy drives microbiome restructuring through improved host physiology in cystic fibrosis: the IMMProveCF phase IV trial

Guardat en:

Dades bibliogràfiques
Publicat a:	Nature Communications vol. 16, no. 1 (2025), p. 10111-10127
Autor principal:	Knoll, Rebecca Luise
Altres autors:	Brauny, Melanie Meihua, Robert, Evelyn, Cloos, Louisa, Waser, Lydia, Hilbert, Katja, Ulmer, Nina, Hillen, Barlo, Birkner, Till, Bartolomaeus, Theda Ulrike Patricia, Nitsche, Oliver, Jarquín-Díaz, Víctor Hugo, Lynch, Susan, Gehring, Stephan, Maier, Lisa, Poplawska, Krystyna, Forslund-Startceva, Sofia Kirke
Publicat:	Nature Publishing Group
Matèries:	Physiology Cystic fibrosis transmembrane conductance regulator rRNA 16S Longitudinal studies Modulators Mutation Antibacterial activity Species diversity Gastrointestinal tract Inflammation Feces Cystic fibrosis Microbiomes Intestinal microflora Microorganisms Lungs Age Sputum Gene sequencing Species richness Antibiotics Respiratory function Dysbacteriosis Gut microbiota Genetic disorders Digestive system Escherichia Staphylococcus Environmental
Accés en línia:	Citation/Abstract Full Text Full Text - PDF
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!